Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Breast Adenocarcinoma|Invasive Breast Carcinoma|Malignant Solid Neoplasm
Interventions: PROCEDURE: Biopsy|OTHER: Blood Sample|PROCEDURE: Bone Scan|PROCEDURE: Computed Tomography|DRUG: Entinostat|BIOLOGICAL: Ipilimumab|BIOLOGICAL: Nivolumab|OTHER: Pharmacogenomic Study|OTHER: Pharmacological Study|PROCEDURE: Positron Emission Tomography
Sponsor: National Cancer Institute (NCI)